Centauri Therapeutics Ltd.

Biotech valuations and funding availability went into reverse in the second half of 2021, following a period of abundant financing. Meanwhile, big pharma companies face their own problems, with many b

A long-time participant in the push against the rise of antibiotic-resistant infections, Boehringer Ingelheim GmbH has now teamed up with Evotec SE and bioMerieux SA to form a joint venture to i

A new UK-based company, RQ Biotechnology, has emerged from stealth mode via a deal with AstraZeneca to license six early-stage COVID-19 monoclonal antibody candidates worth up to $157m plus royaltie

Venture capital investors showed biopharmaceutical start-ups and growth-stage private companies some love with a trio of $100m-plus financings announced on 14 and 16 February, including a $236m series